Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial
- 세원 정
- 2024년 11월 8일
- 1분 분량
[논문]Ah-Young Kim, Seonyoung Park, 이한길, Deborah Baik, Hyeonseok Cho, Sunghwa Cho, Hye-Young Kang, Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial, BMC CANCER, pp.1157- pp.1157 (11월, 2020)